Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

[Patients' perspective of living with PAH or CTEPH in Sweden].

Ivarsson B, Hesselstrand R, Rådegran G, Kjellström B.

Lakartidningen. 2019 May 1;116. pii: FITF. Swedish.

2.

Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication.

Andréasson K, Jönsson G, Hesselstrand R, Norrgren H.

World J Hepatol. 2019 Mar 27;11(3):330-334. doi: 10.4254/wjh.v11.i3.330.

3.

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.

Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E, Castellví I, Airó P, Vettori S, De Langhe E, Hachulla E, Erler A, Ananieva L, Krusche M, López-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri V, Hsu VM, Pozzi MR, Ancuta C, Rosato E, Mihai C, Kuwana M, Saketkoo LA, Chizzolini C, Hesselstrand R, Ullman S, Yavuz S, Rednic S, Caimmi C, Bloch-Queyrat C, Allanore Y; for EUSTAR network.

Ann Rheum Dis. 2019 Jul;78(7):979-987. doi: 10.1136/annrheumdis-2018-214816. Epub 2019 Apr 9.

PMID:
30967395
4.

Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Ivarsson B, Sjöberg T, Hesselstrand R, Rådegran G, Kjellström B.

ERJ Open Res. 2019 Feb 25;5(1). pii: 00218-2018. doi: 10.1183/23120541.00218-2018. eCollection 2019 Feb.

5.

Validity of the Swedish version of the systemic sclerosis quality of life questionnaire (SSCQoL): A novel measure of quality of life for patients with systemic sclerosis.

Sandqvist G, Hesselstrand R.

Ann Rheum Dis. 2019 Jun;78(6):855-857. doi: 10.1136/annrheumdis-2018-214260. Epub 2019 Jan 4. No abstract available.

PMID:
30610065
6.

Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.

Lindholm A, Hesselstrand R, Rådegran G, Arheden H, Ostenfeld E.

Clin Physiol Funct Imaging. 2019 May;39(3):215-225. doi: 10.1111/cpf.12561. Epub 2019 Jan 16.

PMID:
30597705
7.

Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.

Carreira PE, Carmona L, Joven BE, Loza E, Andreu JL, Riemekasten G, Vettori S, Balbir-Gurman A, Airò P, Walker UA, Damjanov N, Matucci-Cerinic M, Ananieva LP, Rednic S, Czirják L, Distler O, Farge D, Hesselstrand R, Corrado A, Caramaschi P, Tikly M, Allanore Y; and the EUSTAR co-authors.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):68-75. Epub 2018 Sep 29.

8.

Increased B-cell activating factor, interleukin-6, and interleukin-8 in induced sputum from primary Sjögren's syndrome patients.

Nilsson AM, Tufvesson E, Hesselstrand R, Olsson P, Wollmer P, Mandl T.

Scand J Rheumatol. 2019 Mar;48(2):149-156. doi: 10.1080/03009742.2018.1473488. Epub 2018 Sep 30.

PMID:
30270699
9.

Nailfold capillaroscopy-how many fingers should be examined to detect abnormality?

Dinsdale G, Roberts C, Moore T, Manning J, Berks M, Allen J, Anderson ME, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Rheumatology (Oxford). 2019 Feb 1;58(2):284-288. doi: 10.1093/rheumatology/key293.

PMID:
30247696
10.

Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database.

Carreira PE, Carmona L, Joven BE, Loza E, Andréu JL, Riemekasten G, Vettori S, Balbir-Gurman A, Airò P, Walker U, Damjanov N, Matucci-Cerinic M, Ananieva LP, Rednic S, Czirják L, Distler O, Farge D, Hesselstrand R, Corrado A, Caramaschi P, Tikly M, Allanore Y.

Scand J Rheumatol. 2019 Jan;48(1):42-51. doi: 10.1080/03009742.2018.1459830. Epub 2018 Jul 24.

PMID:
30039730
11.

Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Ivarsson B, Hesselstrand R, Rådegran G, Kjellström B.

Chron Respir Dis. 2019 Jan-Dec;16:1479972318787906. doi: 10.1177/1479972318787906. Epub 2018 Jul 16.

12.

Increased right atrial volume measured with cardiac magnetic resonance is associated with worse clinical outcome in patients with pre-capillary pulmonary hypertension.

Bredfelt A, Rådegran G, Hesselstrand R, Arheden H, Ostenfeld E.

ESC Heart Fail. 2018 Oct;5(5):864-875. doi: 10.1002/ehf2.12304. Epub 2018 Jun 19.

13.

CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis.

Hoffmann-Vold AM, Hesselstrand R, Fretheim H, Ueland T, Andreassen AK, Brunborg C, Palchevskiy V, Midtvedt Ø, Garen T, Aukrust P, Belperio JA, Molberg Ø.

Arthritis Rheumatol. 2018 Oct;70(10):1644-1653. doi: 10.1002/art.40534. Epub 2018 Aug 30.

PMID:
29687634
14.

Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension.

Kylhammar D, Hesselstrand R, Nielsen S, Scheele C, Rådegran G.

Scand J Rheumatol. 2018 Jul;47(4):319-324. doi: 10.1080/03009742.2017.1378714. Epub 2018 Mar 12.

PMID:
29528272
15.

Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study.

Ndosi M, Alcacer-Pitarch B, Allanore Y, Del Galdo F, Frerix M, García-Díaz S, Hesselstrand R, Kendall C, Matucci-Cerinic M, Mueller-Ladner U, Sandqvist G, Torrente-Segarra V, Schmeiser T, Sierakowska M, Sierakowska J, Sierakowski S, Redmond A.

Ann Rheum Dis. 2018 Jul;77(7):1032-1038. doi: 10.1136/annrheumdis-2017-212412. Epub 2018 Feb 20.

16.

The assessment of nailfold capillaries: comparison of dermoscopy and nailfold videocapillaroscopy.

Dinsdale G, Peytrignet S, Moore T, Berks M, Roberts C, Manning J, Allen J, Anderson M, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Rheumatology (Oxford). 2018 Jun 1;57(6):1115-1116. doi: 10.1093/rheumatology/key018. No abstract available.

PMID:
29447411
17.

Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study.

Gyllenhammar T, Kanski M, Engblom H, Wuttge DM, Carlsson M, Hesselstrand R, Arheden H.

BMC Cardiovasc Disord. 2018 Jan 30;18(1):16. doi: 10.1186/s12872-018-0756-x.

18.

Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis.

Hesselstrand R, Nagel J, Saxne T, Geborek P, Skattum L, Kapetanovic MC.

Rheumatology (Oxford). 2018 Apr 1;57(4):769. doi: 10.1093/rheumatology/key007. No abstract available.

PMID:
29373696
19.

Adherence and medication belief in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A nationwide population-based cohort survey.

Ivarsson B, Hesselstrand R, Rådegran G, Kjellström B.

Clin Respir J. 2018 Jun;12(6):2029-2035. doi: 10.1111/crj.12770. Epub 2018 Feb 5.

PMID:
29356440
20.

Coping, social support and information in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A 2-year retrospective cohort study.

Ivarsson B, Rådegran G, Hesselstrand R, Kjellström B.

SAGE Open Med. 2018 Jan 4;6:2050312117749159. doi: 10.1177/2050312117749159. eCollection 2018.

21.

Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis.

Hesselstrand R, Nagel J, Saxne T, Geborek P, Skattum L, Kapetanovic MC.

Rheumatology (Oxford). 2018 Apr 1;57(4):625-630. doi: 10.1093/rheumatology/kex471. Erratum in: Rheumatology (Oxford). 2018 Apr 1;57(4):769.

PMID:
29325173
22.

Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.

Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, Dinsdale G, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk MC, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jobanputra P, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov NS, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman SM, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2018 Apr;77(4):563-570. doi: 10.1136/annrheumdis-2017-211912. Epub 2018 Jan 6.

23.

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.

Peytrignet S, Denton CP, Lunt M, Hesselstrand R, Mouthon L, Silman A, Pan X, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuta C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, Inanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Herrick AL.

Rheumatology (Oxford). 2018 Feb 1;57(2):370-381. doi: 10.1093/rheumatology/kex410.

24.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
25.

Raynaud's phenomenon and its impact on activities in daily life during one year of follow-up in early systemic sclerosis.

Sandqvist G, Wollmer P, Scheja A, Wildt M, Hesselstrand R.

Scand J Rheumatol. 2018 May;47(3):206-209. doi: 10.1080/03009742.2017.1350745. Epub 2017 Aug 13.

PMID:
28803485
26.

Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis.

Carreira PE, Carmona L, Joven BE, Loza E, Andreu JL, Riemekasten G, Vettori S, Allanore Y, Balbir-Gurman A, Airò P, Walker UA, Damjanov N, Ananieva LP, Rednic S, Czirják L, Distler O, Farge D, Hesselstrand R, Corrado A, Caramaschi P, Tikly M, Matucci-Cerinic M; and EUSTAR co-authors.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):114-121. Epub 2017 Jun 20.

PMID:
28664832
27.

Quantitative outcome measures for systemic sclerosis-related Microangiopathy - Reliability of image acquisition in Nailfold Capillaroscopy.

Dinsdale G, Moore T, O'Leary N, Berks M, Roberts C, Manning J, Allen J, Anderson M, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Microvasc Res. 2017 Sep;113:56-59. doi: 10.1016/j.mvr.2017.05.003. Epub 2017 May 8.

PMID:
28495471
28.

Respiratory symptoms are poor predictors of concomitant chronic obstructive pulmonary disease in patients with primary Sjögren's syndrome.

Strevens Bolmgren V, Olsson P, Wollmer P, Hesselstrand R, Mandl T.

Rheumatol Int. 2017 May;37(5):813-818. doi: 10.1007/s00296-017-3678-5. Epub 2017 Feb 27.

29.

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).

Herrick AL, Pan X, Peytrignet S, Lunt M, Hesselstrand R, Mouthon L, Silman A, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Jobanputra P, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2017 Jul;76(7):1207-1218. doi: 10.1136/annrheumdis-2016-210503. Epub 2017 Feb 10.

30.

Intra-and inter-observer reliability of nailfold videocapillaroscopy - A possible outcome measure for systemic sclerosis-related microangiopathy.

Dinsdale G, Moore T, O'Leary N, Tresadern P, Berks M, Roberts C, Manning J, Allen J, Anderson M, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Microvasc Res. 2017 Jul;112:1-6. doi: 10.1016/j.mvr.2017.02.001. Epub 2017 Feb 2.

PMID:
28163035
31.

The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease: a multicentre European Scleroderma Trials and Research group (EUSTAR) study.

Kowal-Bielecka O, Chwiesko-Minarowska S, Bernatowicz PL, Allanore Y, Radstake T, Matucci-Cerinic M, Broen J, Hesselstrand R, Krasowska D, Riemekasten G, Vonk M, Kowalczuk O, Bielecki M, Milewski R, Chyczewski L, Niklinski J, Kowal K.

Rheumatology (Oxford). 2017 May 1;56(5):844-852. doi: 10.1093/rheumatology/kew499.

PMID:
28160477
32.

Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.

Lazzaroni MG, Cavazzana I, Colombo E, Dobrota R, Hernandez J, Hesselstrand R, Varju C, Nagy G, Smith V, Caramaschi P, Riccieri V, Hachulla E, Balbir-Gurman A, Chatelus E, Romanowska-Próchnicka K, Araújo AC, Distler O, Allanore Y, Airò P; EUSTAR co-authors.

J Rheumatol. 2017 May;44(5):639-647. doi: 10.3899/jrheum.160817. Epub 2017 Jan 15.

PMID:
28089973
33.

Information, social support and coping in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension-A nationwide population-based study.

Ivarsson B, Rådegran G, Hesselstrand R, Kjellström B.

Patient Educ Couns. 2017 May;100(5):936-942. doi: 10.1016/j.pec.2016.12.021. Epub 2016 Dec 21.

PMID:
28041647
34.

Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus.

Lood C, Tydén H, Gullstrand B, Nielsen CT, Heegaard NH, Linge P, Jönsen A, Hesselstrand R, Kahn R, Bengtsson AA.

Rheumatology (Oxford). 2017 Mar 1;56(3):408-416. doi: 10.1093/rheumatology/kew437.

PMID:
28031442
35.

Effects of intense pulsed light in microstomia in patients with systemic sclerosis: A pilot study.

Rosholm Comstedt L, Svensson Å, Hesselstrand R, Lehti L, Troilius Rubin A.

J Cosmet Laser Ther. 2017 Jun;19(3):143-148. doi: 10.1080/14764172.2016.1262961. Epub 2017 Feb 2.

PMID:
27911118
36.

Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis.

Okrój M, Johansson M, Saxne T, Blom AM, Hesselstrand R.

Arthritis Res Ther. 2016 Nov 18;18(1):267.

37.

Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.

Rådegran G, Kjellström B, Ekmehag B, Larsen F, Rundqvist B, Blomquist SB, Gustafsson C, Hesselstrand R, Karlsson M, Kornhall B, Nisell M, Persson L, Ryftenius H, Selin M, Ullman B, Wall K, Wikström G, Willehadson M, Jansson K; Stefan Söderberg j , on behalf of SveFPH and SPAHR.

Scand Cardiovasc J. 2016 Aug;50(4):243-50. doi: 10.1080/14017431.2016.1185532. Epub 2016 Jun 14.

PMID:
27146648
38.

The Modified Hand Mobility in Scleroderma Test and Skin Involvement - A Followup Study.

Sandqvist G, Wuttge DM, Hesselstrand R.

J Rheumatol. 2016 Jul;43(7):1356-62. doi: 10.3899/jrheum.151142. Epub 2016 May 1.

PMID:
27134250
39.

Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies.

López-Isac E, Martín JE, Assassi S, Simeón CP, Carreira P, Ortego-Centeno N, Freire M, Beltrán E, Narváez J, Alegre-Sancho JJ; Spanish Scleroderma Group, Fernández-Gutiérrez B, Balsa A, Ortiz AM, González-Gay MA, Beretta L, Santaniello A, Bellocchi C, Lunardi C, Moroncini G, Gabrielli A, Witte T, Hunzelmann N, Distler JH, Riekemasten G, van der Helm-van Mil AH, de Vries-Bouwstra J, Magro-Checa C, Voskuyl AE, Vonk MC, Molberg Ø, Merriman T, Hesselstrand R, Nordin A, Padyukov L, Herrick A, Eyre S, Koeleman BP, Denton CP, Fonseca C, Radstake TR, Worthington J, Mayes MD, Martín J.

Arthritis Rheumatol. 2016 Sep;68(9):2338-44. doi: 10.1002/art.39730.

40.

Limited impact of fibromodulin deficiency on the development of experimental skin fibrosis.

Andréasson K, Gustafsson R, Rydell-Törmänen K, Westergren-Thorsson G, Saxne T, Hesselstrand R.

Exp Dermatol. 2016 Jul;25(7):558-61. doi: 10.1111/exd.13012.

PMID:
26997256
41.

CD81 and CD48 show different expression on blood eosinophils in systemic sclerosis: new markers for disease and pulmonary inflammation?

Wuttge DM, Andreasson A, Tufvesson E, Johansson ÅC, Scheja A, Hellmark T, Hesselstrand R, Truedsson L.

Scand J Rheumatol. 2016;45(2):107-13. doi: 10.3109/03009742.2015.1054877. Epub 2015 Nov 17.

PMID:
26926492
42.

Airway resistance and reactance are affected in systemic sclerosis.

Aronsson D, Hesselstrand R, Bozovic G, Wuttge DM, Tufvesson E.

Eur Clin Respir J. 2015 Oct 21;2:28667. doi: 10.3402/ecrj.v2.28667. eCollection 2015.

43.

High frequency ultrasound of skin involvement in systemic sclerosis - a follow-up study.

Hesselstrand R, Carlestam J, Wildt M, Sandqvist G, Andréasson K.

Arthritis Res Ther. 2015 Nov 19;17:329. doi: 10.1186/s13075-015-0853-5.

44.

Cartilage oligomeric matrix protein: a new promising biomarker of liver fibrosis in chronic hepatitis C.

Andréasson K, Hesselstrand R, Saxne T, Holmberg A, Norrgren H, Jönsson G.

Infect Dis (Lond). 2015;47(12):915-8. Epub 2015 Aug 12.

PMID:
26269256
45.

Work Disability in Early Systemic Sclerosis: A Longitudinal Population-based Cohort Study.

Sandqvist G, Hesselstrand R, Petersson IF, Kristensen LE.

J Rheumatol. 2015 Oct;42(10):1794-800. doi: 10.3899/jrheum.150023. Epub 2015 Aug 1.

PMID:
26233502
46.

Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis.

Wuttge DM, Carlsen AL, Teku G, Steen SO, Wildt M, Vihinen M, Hesselstrand R, Heegaard NH.

Rheumatology (Oxford). 2015 Nov;54(11):2100-7. doi: 10.1093/rheumatology/kev234. Epub 2015 Jul 10.

PMID:
26163687
47.

Chronic obstructive pulmonary disease is common in never-smoking patients with primary Sjögren syndrome.

Nilsson AM, Diaz S, Theander E, Hesselstrand R, Piitulainen E, Ekberg O, Wollmer P, Mandl T.

J Rheumatol. 2015 Mar;42(3):464-71. doi: 10.3899/jrheum.140370. Epub 2015 Jan 15.

PMID:
25593235
48.

Personal factors in systemic sclerosis and their coverage by patient-reported outcome measures. A multicentre European qualitative study and literature review.

Mattsson M, Boström C, Mihai C, Stöcker J, Geyh S, Stummvoll G, Gard G, Möller B, Hesselstrand R, Sandqvist G, Draghicescu O, Gherghe AM, Voicu M, Distler O, Smolen JS, Stamm TA.

Eur J Phys Rehabil Med. 2015 Aug;51(4):405-21. Epub 2015 Jan 9. Review.

49.

Perceptions of received information, social support, and coping in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Ivarsson B, Ekmehag B, Hesselstrand R, Rådegran G, Sjöberg T.

Clin Med Insights Circ Respir Pulm Med. 2014 Oct 23;8:21-8. doi: 10.4137/CCRPM.S18586. eCollection 2014.

50.

Development of a modified hand mobility in scleroderma (HAMIS) test and its potential as an outcome measure in systemic sclerosis.

Sandqvist G, Nilsson JÅ, Wuttge DM, Hesselstrand R.

J Rheumatol. 2014 Nov;41(11):2186-92. doi: 10.3899/jrheum.140286. Epub 2014 Oct 1.

PMID:
25274889

Supplemental Content

Loading ...
Support Center